The Journal of Cell Communication and Signaling provides a forum for fundamental and translational research. In particular, it publishes papers discussing intercellular and intracellular signaling pathways that are particularly important to understand how cells interact with each other and with the surrounding environment, and how cellular behavior contributes to pathological states. JCCS encourages the submission of research manuscripts, timely reviews and short commentaries discussing recent publications, key developments and controversies.
Research manuscripts can be published under two different sections :.
In the Pathology and Translational Research Section (Section Editor Andrew Leask) , manuscripts report original research dealing with celllular aspects of normal and pathological signaling and communication, with a particular interest in translational research.
In the Molecular Signaling Section (Section Editor Satoshi Kubota) manuscripts report original signaling research performed at molecular levels with a particular interest in the functions of intracellular and membrane components involved in cell signaling.
The Review Section (Section Editor David Brigstock) is a venue for publication of review articles that summarize recent advances and discoveries, identify gaps and debates, and outline future directions in all aspects of cell signaling and communication. The Journal is particularly interested in focused and authoratative mini-reviews that will allow the reader to gain a rapid understanding of the material presented. Mini-reviews should not exceed 5000 words, excluding the abstract and bibliography. No more than 80 references should be cited. Inclusion of figures to help summarize the major concepts is encouraged. Authors are requested to contact the Section Editor with a proposed outline of their article before subm ission so that its suitability for publication in the journal can be assessed.
The ‘At the Forefront of Unforeseen Science’ section (Section Editor Bernard Perbal publishes peer-reviewed articles reporting on groundbreaking discoveries that promise to have an impact on the future of mankind. The manuscripts should be written in the form of a concise analysis and review of exciting advances in any scientific field that will offer novel perspectives that could open new avenues for research and applications
The Bits & Bytes section (Section Editors Andrew Leask and Herman Yeger) provides a forum for the rapid distribution of short commentaries on recent publications and news that are of interest to the scientific community. These commentaries also appear on the Web site of the International CCN Society (http://ccnsociety.com) as soon as they are accepted.
Letters to the Editor, which should be original research manuscripts reporting findings of wide interest to the scientific community. Letters typically do not exceed 2-4 pages and report early but ground breaking studies that deserve accelerated processing. The letters undergo strict peer review. The number of figures and or tables is limited to 3. The text is not to exceed 2000 words, and reference should be kept to a minimum. The preliminary review process is conducted under the responsibility of the Editor in Chief. Manuscripts that do not comply with the 'Letter' requirements are transferred to regular section editors.
About the Editors:
Bernard Perbal : http://ccnsociety.com/about_the_iccns/president.html
Andrew Leask : http://ccnsociety.com/about_the_iccns/member_a_leask.html
Satoshi Kubota : http://ccnsociety.com/about_the_iccns/member_s_kubota.html
David Brigstock : http://ccnsociety.com/about_the_iccns/member_d_brigstock.html
General Details on the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online and Print Color Images
- Optional Open Access Publication Fee (APC) – USD 3000,- / Euro 2200,-
- Addresses all aspects of cell-cell, cell-matrix communication, and intracellular signaling
- Covers receptors, ligands, and other biomolecules participating in cellular signaling pathways
- Andrew Leask
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
- 3.788 (2019)
- Impact factor
- 3.692 (2019)
- Five year impact factor
- 16 days
- Submission to first decision
- 105 days
- Submission to acceptance
- 70,669 (2020)
Metastases from metastases: comparative metastatic potential of human cancer cell lines originated from primary tumors or metastases in various tissues
Sequence features, structure, ligand interaction, and diseases in small leucine rich repeat proteoglycans
Authors (first, second and last of 5)
Authors (first, second and last of 4)
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- Biological Abstracts
- EBSCO Discovery Service
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Natural Science Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)